Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib

NCT06516029 · clinicaltrials.gov ↗
COMPLETED
Status
111
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Novartis